{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T02:20:21Z","timestamp":1774059621912,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2025-MSLH-809"],"award-info":[{"award-number":["2025-MSLH-809"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.euros.2026.01.008","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:08:46Z","timestamp":1770840526000},"page":"97-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Re: Rui M. Bernardino, Leyi B. Yin, Katherine Lajkosz, et al. Intraductal Carcinoma Predicts Poor Response to Neoadjuvant Therapy in High-risk Prostate Cancer: A Retrospective Analysis of a Prospective Trial. Eur Urol Open Sci 2025;82:52\u20138"],"prefix":"10.1016","volume":"85","author":[{"given":"Wei","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.01.008_b0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.euros.2025.09.015","article-title":"Intraductal carcinoma predicts poor response to neoadjuvant therapy in high-risk prostate cancer: a retrospective analysis of a prospective trial","volume":"82","author":"Bernardino","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2026.01.008_b0010","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/PAS.0000000000001728","article-title":"ISUP consensus definition of cribriform pattern prostate cancer","volume":"45","author":"van der Kwast","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euros.2026.01.008_b0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.eururo.2017.03.013","article-title":"Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories","volume":"72","author":"Porter","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.01.008_b0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.euros.2026.01.008_b0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41391-024-00910-3","article-title":"Undetected cribriform and intraductal prostate cancer at biopsy is associated with adverse outcomes","volume":"28","author":"Bernardino","year":"2025","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euros.2026.01.008_b0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.eururo.2025.01.015","article-title":"Long-term outcomes and prognostic impact of residual cancer burden after intensified neoadjuvant therapy in high-risk prostate cancer","volume":"87","author":"Ravi","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.01.008_b0035","doi-asserted-by":"crossref","first-page":"25065","DOI":"10.1038\/s41598-024-75272-w","article-title":"Profiling of urinary extracellular vesicle protein signatures from patients with cribriform and intraductal prostate carcinoma in a cross-sectional study","volume":"14","author":"Bernardino","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.euros.2026.01.008_b0040","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:46:45Z","timestamp":1774057605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":8,"alternative-id":["S2666168326000157"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.01.008","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re: Rui M. Bernardino, Leyi B. Yin, Katherine Lajkosz, et al. Intraductal Carcinoma Predicts Poor Response to Neoadjuvant Therapy in High-risk Prostate Cancer: A Retrospective Analysis of a Prospective Trial. Eur Urol Open Sci 2025;82:52\u20138","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}